Cigna Group (NYSE:CI) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Analyst consensus: Twenty-one brokerages give Cigna a "Moderate Buy" consensus (16 buys, 4 holds, 1 strong buy) with an average 12‑month target of $336.20.
• Quarterly beat and outlook: Cigna beat Q1 expectations (EPS $7.79 vs. $7.60; revenue $68.52B vs. $66.29B) and raised FY‑2026 adjusted EPS guidance to about $30.35, supporting upside to valuation.
• Key risk: Cigna plans to exit the Affordable Care Act individual exchange business in 2027, affecting roughly 369,000 members and creating near‑term topline and execution/transition risk.

Shares of Cigna Group (NYSE:CI - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty-one research firms that are covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $336.20.

CI has been the subject of several research reports. Piper Sandler reduced their target price on Cigna Group from $374.00 to $370.00 and set an "overweight" rating for the company in a report on Tuesday, March 3rd. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday. Leerink Partners boosted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a research note on Friday, February 6th. Robert W. Baird set a $337.00 price objective on Cigna Group in a research note on Friday. Finally, Guggenheim reiterated a "buy" rating and issued a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd.

Cigna Group Price Performance

Shares of CI opened at $283.14 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The stock has a market cap of $74.62 billion, a PE ratio of 12.00, a price-to-earnings-growth ratio of 0.98 and a beta of 0.30. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.74. The firm has a fifty day moving average price of $274.34 and a 200 day moving average price of $276.81.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. During the same period in the previous year, the company earned $6.74 earnings per share. Cigna Group's quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.41 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group's dividend payout ratio is 28.13%.

Trending Headlines about Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an "outperform" rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares of the company's stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Cigna Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its stake in shares of Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider's stock worth $7,203,754,000 after purchasing an additional 414,834 shares during the last quarter. State Street Corp raised its stake in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider's stock worth $3,396,132,000 after purchasing an additional 224,122 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock worth $3,249,113,000 after purchasing an additional 903,334 shares during the last quarter. Dodge & Cox raised its stake in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the last quarter. Finally, Sanders Capital LLC raised its stake in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider's stock worth $2,256,469,000 after purchasing an additional 35,150 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.